C
Power Law company profile
Caris Life Sciences
Biotech & Life Sciences · Irving, United States · Founded 1996 · IPO 2025 Unicorn
Valuation
$4.65B
Market cap · Apr/2026
Revenue
$800M
Latest reported FY
Global footprint
Where Caris Life Sciences has talent and traffic
AI talent share
1.7%
of workforce is AI talent
(27 of 1,600 staff)
(27 of 1,600 staff)
Core AI60.38%
Other AI211.31%
Non-AI workforce1,57398.31%
Web traffic by country
43K
monthly visits
across markets
across markets
🇺🇸 United States63%
🇨🇦 Canada5.8%
🇯🇵 Japan4.9%
🇮🇳 India4.7%
🇩🇪 Germany4%
Patent intelligence
$42M patent portfolio · 24 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$42M
0.90% of market cap · 18.6× smaller than top peer BioNTech ($780M)
24 active patent families
Where Caris Life Sciences innovates
Biologic markerDiseaseBioinformaticsMolecular biologyCancer research
Tracks the peer median across all five Patsnap quality dimensions.
Quality vs same-sector peers
Caris Life Sciences on the five Patsnap quality dimensions
Caris Life Sciences in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Caris Life Sciences concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Caris Life Sciences and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Caris Life Sciences on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.